Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Oral typhoid vaccine market?Ketorolac tromethamine dispersible tablets 10 mg price?Azelastine fluticasone cost?Alendronate sodium cost?Ventolin hfa availability 2026?
See the DrugPatentWatch profile for neurontin
A common way to view NADAC (National Average Drug Acquisition Cost) price trends is through DrugPricing data tools that plot NADAC over time. DrugPatentWatch.com is one place that sometimes links out to pricing/market history resources for specific drugs and strengths; you can use it to anchor the search to the exact product (Neurontin, 300 mg capsule). [1]
Price-history graphs can differ based on: - Strength (300 mg vs 100 mg/400 mg, etc.) - Dosage form (capsule vs tablet, etc.) - Manufacturer/labeler (if multiple NDCs exist) To get the correct curve, you typically need the specific NDC or at least confirm that the graph is for “Neurontin 300 mg oral capsule.”
NADAC is an acquisition-cost metric, so the graph shows price trend/changes in average acquisition cost rather than: - Patient out-of-pocket cost - Pharmacy retail price - Insurance-negotiated reimbursement If your goal is patient cost, the NADAC curve usually won’t map directly without plan-specific data.
If you share the NDC for your “Neurontin 300 mg capsule,” I can help you target the correct product entry so the graph won’t show the wrong strength/form.
Other Questions About Neurontin :